Rahman I, Skwarska E, MacNee W
Department of Medicine, Royal Infirmary, Edinburgh, UK.
Thorax. 1997 Jun;52(6):565-8. doi: 10.1136/thx.52.6.565.
An oxidant/antioxidant imbalance is thought to occur in patients with chronic obstructive pulmonary disease (COPD). It has recently been shown that during exacerbations of COPD the antioxidant capacity and protein sulfhydryls of plasma are lower and the levels of products of lipid peroxidation are higher than in age matched healthy subjects. The aims of this study were to confirm these data and to measure the time course of these changes.
The plasma Trolox equivalent antioxidant capacity (TEAC), protein sulfhydryls, and products of lipid peroxidation were measured throughout the course of treatment in 13 patients who presented with an acute exacerbation of COPD.
TEAC values (mmol/l) were low on admission (mean 0.67, 95% confidence interval (CI) 0.32 to 0.88; p < 0.05) and had increased by discharge (0.98, 95% CI 0.88 to 1.2; p < 0.05) but still remained lower than in healthy subjects (1.33, 95% CI 1.11 to 1.65). There was also restoration of plasma protein sulfhydryl levels (mmol/l) from admission (0.32, 95% CI 0.20 to 0.43) to discharge (0.49, 95% CI 0.42 to 0.62, p < 0.001) to levels similar to those in healthy subjects (0.52, 95% CI 0.43 to 0.65). Products of lipid peroxidation, measured as thiobarbituric acid-malondialdehyde adducts (mumol/l), were significantly higher (2.08, 95% CI 1.8 to 2.5) than in control subjects (1.3, 95% CI 0.85 to 1.32; p < 0.01) and returned to normal values by the time of discharge (1.2, 95% CI 0.88 to 1.29).
These data confirm the presence of a profound oxidant/antioxidant imbalance in the blood of patients with acute exacerbations of COPD which returns towards normal values during the course of treatment.
氧化应激/抗氧化失衡被认为发生在慢性阻塞性肺疾病(COPD)患者中。最近研究表明,在COPD急性加重期,患者血浆抗氧化能力和蛋白质巯基水平低于年龄匹配的健康受试者,脂质过氧化产物水平则高于健康受试者。本研究旨在证实这些数据,并测定这些变化的时间进程。
对13例COPD急性加重期患者在整个治疗过程中测定血浆特洛克斯等效抗氧化能力(TEAC)、蛋白质巯基和脂质过氧化产物水平。
入院时TEAC值(mmol/L)较低(均值0.67,95%置信区间(CI)0.32至0.88;p<0.05),出院时升高(0.98,95%CI 0.88至1.2;p<0.05),但仍低于健康受试者(1.33,95%CI 1.11至1.65)。血浆蛋白质巯基水平(mmol/L)也从入院时(0.32,95%CI 0.20至0.43)恢复至出院时(0.49,95%CI 0.42至0.62,p<0.001),与健康受试者水平(0.52,95%CI 0.43至0.65)相似。以硫代巴比妥酸-丙二醛加合物(μmol/L)衡量的脂质过氧化产物水平显著高于对照组(2.08,95%CI 1.8至2.5)(对照组为1.3,95%CI 0.85至1.32;p<0.01),出院时恢复至正常水平(1.2,95%CI 0.88至1.29)。
这些数据证实了COPD急性加重期患者血液中存在严重的氧化应激/抗氧化失衡,且在治疗过程中趋于恢复正常水平。